BioXcel Therapeutics (BTAI) Granted FDA Fast Track Designation for BXCL501 for Acute Treatment of Agitation - https://t.co/gM21sWBOiB https://t.co/CW572zIYHO
— IDRO (@IDROOhio) December 27, 2018
from Twitter https://twitter.com/IDROOhio
December 27, 2018 at 11:45AM
No comments:
Post a Comment